secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001493152-23-039443
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences enters $10M common stock purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Lincoln Park commits to buy up to $10M of Enveric common stock over 24 months at the company's discretion.
- Company issued 139,403 commitment shares as consideration for Lincoln Park's commitment.
- Purchase price per share based on market prices; regular purchases up to 25,000 shares per day with potential increases.
- Proceeds to be used for general corporate purposes including R&D, working capital, and possible acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/0001493152-23-039443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer